- Patterns of adverse reactions for immune checkpoint inhibitors in cancer patients with central nervous system metastasesGu, T.; Yang, H.; Shen, J.; Lin, A.; Zhang, J.; Luo, P.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- Evaluation of immune checkpoint inhibitors rechallenge after immune-related adverse events in patients with cancerTang, X-R.; Li, R.; Zhao, F.; Wen, X.; Wang, Y-K.; Lv, R-X.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
- Treatment-related adverse events as surrogate to response rate to immune checkpoint blockadeYanyun, Shen; Yunfeng, Chen; Duoqin, Wang; Zhidong, ZhuMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2020, 99(37): e22153.
会议论文
Psychiatric disorders associated with immune checkpoint inhibitors
12阅读
